Recent progress and perspectives on prostate cancer biomarkers
S Hatakeyama, T Yoneyama, Y Tobisawa… - International journal of …, 2017 - Springer
The application of prostate-specific antigen (PSA) in prostate cancer (PC) screening,
diagnosis, and prognosis has improved the clinical management of PC patients. However …
diagnosis, and prognosis has improved the clinical management of PC patients. However …
Serum markers for prostate cancer: a rational approach to the literature
T Steuber, MF O'Brien, H Lilja - European urology, 2008 - Elsevier
INTRODUCTION: Due to its universal applicability for early detection and prediction of
cancer stage and disease recurrence, widespread implementation of serum-based prostate …
cancer stage and disease recurrence, widespread implementation of serum-based prostate …
Beyond PSA: the next generation of prostate cancer biomarkers
JR Prensner, MA Rubin, JT Wei… - Science translational …, 2012 - science.org
Since the introduction of serum prostate-specific antigen (PSA) screening 25 years ago,
prostate cancer diagnosis and management have been guided by this biomarker. Yet, PSA …
prostate cancer diagnosis and management have been guided by this biomarker. Yet, PSA …
[HTML][HTML] Clinical utility of current biomarkers for prostate cancer detection
JH Kim, SK Hong - Investigative and clinical urology, 2021 - ncbi.nlm.nih.gov
Although prostate-specific antigen (PSA) remains the most used test to detect prostate
cancer (PCa), the limited specificity and an elevated rate of overdiagnosis are the main …
cancer (PCa), the limited specificity and an elevated rate of overdiagnosis are the main …
Biomarkers for prostate cancer: prostate-specific antigen and beyond
MJ Duffy - Clinical Chemistry and Laboratory Medicine (CCLM), 2020 - degruyter.com
In recent years, several new biomarkers supplementing the role of prostate-specific antigen
(PSA) have become available for men with prostate cancer. Although widely used in an ad …
(PSA) have become available for men with prostate cancer. Although widely used in an ad …
Biomarkers for prostate cancer detection and risk stratification
Although prostate cancer (PCa) is the most commonly diagnosed cancer in men, most
patients do not die from the disease. Prostate specific antigen (PSA), the most widely used …
patients do not die from the disease. Prostate specific antigen (PSA), the most widely used …
Prostate-specific antigen testing across the spectrum of prostate cancer
MR Haythorn, RJ Ablin - Biomarkers in medicine, 2011 - Taylor & Francis
Prostate-specific antigen (PSA) is a protein produced by the prostate, and this protein may
be elevated for several reasons, including prostatitis, benign prostatic hypertrophy and/or …
be elevated for several reasons, including prostatitis, benign prostatic hypertrophy and/or …
Novel biomarkers for the detection of prostate cancer
NA Jakobsen, FC Hamdy… - Journal of Clinical …, 2016 - journals.sagepub.com
Prostate-specific antigen (PSA) is widely used as a biomarker in the detection of prostate
cancer and for decision making regarding treatment options, response to therapy, and …
cancer and for decision making regarding treatment options, response to therapy, and …
PSA and beyond: alternative prostate cancer biomarkers
S Saini - Cellular Oncology, 2016 - Springer
Background The use of biomarkers for prostate cancer screening, diagnosis and prognosis
has the potential to improve the clinical management of the patients. Owing to inherent …
has the potential to improve the clinical management of the patients. Owing to inherent …
Biomarkers in prostate cancer surveillance and screening: past, present, and future
KC Cary, MR Cooperberg - Therapeutic advances in urology, 2013 - journals.sagepub.com
The use of biomarkers for prostate cancer (PCa) screening, detection, and prognostication
have revolutionized the diagnosis and management of the disease. Current clinical practice …
have revolutionized the diagnosis and management of the disease. Current clinical practice …